World's Best Scientists 2026 revealed!
Rita Raisman-Vozari

Rita Raisman-Vozari

D-Index & Metrics

Neuroscience

D-Index
49
Citations
9462
World Ranking
5955
National Ranking
261

Overview

Rita Raisman-Vozari is affiliated with Université Paris Cité in France. Their research primarily spans the fields of Medicine and Neuroscience, with significant focus on Neurology, Physiology, Cellular and Molecular Neuroscience, Pharmacology, and Molecular Biology.

The scientist has contributed extensively to topics including Parkinson's Disease Mechanisms and Treatments, Alzheimer's Disease Research and Treatments, Neuroinflammation and Neurodegeneration Mechanisms, Neuroscience and Neuropharmacology Research, Botulinum Toxin and Related Neurological Disorders, Tryptophan and Brain Disorders, and Cholinesterase and Neurodegenerative Diseases.

Their recent publications include the following papers:

  • Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo, 2021, Neurobiology of Disease
  • Intranasal glyphosate-based herbicide administration alters the redox balance and the cholinergic system in the mouse brain, 2020, NeuroToxicology
  • Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity, 2021, Frontiers in Aging Neuroscience
  • Doxycycline and its derivative, COL-3, decrease dyskinesia induced by l-DOPA in hemiparkinsonian rats, 2021, British Journal of Pharmacology
  • Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson's Disease, 2021, Frontiers in Pharmacology

Rita Raisman-Vozari frequently publishes in notable scientific journals, including IBRO Neuroscience Reports, Cells, Frontiers in Pharmacology, Scientific Reports, and ChemMedChem.

The scientist collaborates regularly with several co-authors, notably Patrick P. Michel, Elaine Aparecida Del Bel, Rosana Chehín, Bruno Figadère, and Laurent Ferrié.

Best Publications

  • Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

    M.G Murer;Q Yan;R Raisman-Vozari

  • Levodopa in the treatment of Parkinson's disease: current controversies.

    C. Warren Olanow;Yves Agid;Yoshi Mizuno;Alberto Albanese

  • Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.

    Julio Salazar;Natalia Mena;Stephane Hunot;Annick Prigent

  • Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

    K. Parain;M. G. Murer;Qiao Yan;B. Faucheux

  • Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

    M G Murer;G Dziewczapolski;L B Menalled;M C García

  • Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements.

    M. Vila;C. Périer;J. Féger;J. Yelnik

  • An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.

    M.G Murer;F Boissiere;Q Yan;S Hunot

  • Oxidative Stress Caused by Ozone Exposure Induces Loss of Brain Repair in The Hippocampus of Adult Rats

    Selva Rivas-Arancibia;Rosalinda Guevara-Guzmán;Yolanda López-Vidal;Erika Rodríguez-Martínez

  • Are dopaminergic neurons selectively vulnerable to Parkinson's disease ?

    Y Agid;M Ruberg;F Javoy-Agid;E Hirsch

  • Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon

    Veronique Blanchard;Rita Raisman-Vozari;Sheela Vyas;Patrick P. Michel

  • Novel tactics for neuroprotection in Parkinson's disease: Role of antibiotics, polyphenols and neuropeptides

    Dora Reglodi;Justine Renaud;Andrea Tamas;Yousef Tizabi

  • Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways

    Flávia V Santa-Cecília;Benjamin Socias;Mohand O Ouidja;Julia E Sepulveda-Diaz

  • Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.

    Henry Jp;Botton D;Sagne C;Isambert Mf

  • Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.

    Rui D. S. Prediger;Aderbal S. Aguiar;Argelia Esperanza Rojas-Mayorquin;Argelia Esperanza Rojas-Mayorquin;Argelia Esperanza Rojas-Mayorquin;Claudia P. Figueiredo

  • Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption.

    Mauricio dos‐Santos‐Pereira;Mauricio dos‐Santos‐Pereira;Franscisco S. Guimarães;Elaine Del‐Bel;Rita Raisman‐Vozari

  • Effects of exercise on mitochondrial function, neuroplasticity and anxio-depressive behavior of mice.

    A.S. Aguiar;E. Stragier;D. da Luz Scheffer;A.P. Remor

  • Levodopa in the treatment of Parkinson's disease: a consensus meeting.

    Y. Agid;E. Ahlskog;A. Albanese;D. Calne

  • Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.

    Daniel Rial;Adalberto A. Castro;Nuno Machado;Pedro Garção

  • The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells.

    Pamela Rizk;Julio Salazar;Julio Salazar;Rita Raisman-Vozari;Rita Raisman-Vozari;Marc Marien

  • Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species.

    Florencia González-Lizárraga;Sergio B. Socías;César L. Ávila;Clarisa M. Torres-Bugeau

  • Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease

    Mariza Bortolanza;Roberta Cavalcanti-Kiwiatkoski;Fernando E. Padovan-Neto;Célia Aparecida da-Silva

Frequent Co-Authors

Yves Agid
Yves Agid Institut du Cerveau
Oscar S. Gershanik
Oscar S. Gershanik Favaloro University
Etienne C. Hirsch
Etienne C. Hirsch Sorbonne University
Laurence Lanfumey
Laurence Lanfumey Université Paris Cité
Claude Feuerstein
Claude Feuerstein Joseph Fourier University
Marc Savasta
Marc Savasta Grenoble Alpes University
Catherine Verney
Catherine Verney Grenoble Alpes University
F. Javoy-Agid
F. Javoy-Agid Pitie-Salpetriére Hospital
Alexis Brice
Alexis Brice Institut du Cerveau

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Rita Raisman-Vozari

Trending Scientists